Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125860641 | 12586064 | 1 | I | 2016 | 20160711 | 20160725 | 20160725 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120754 | RANBAXY | 83.00 | YR | M | Y | 71.00000 | KG | 20160725 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125860641 | 12586064 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Oral | 500 MG X 2 TABLETS | 88958 | MG | U | 91183 | 500 | MG | Q12H | ||||
| 125860641 | 12586064 | 2 | SS | Warfarin | WARFARIN | 1 | Oral | AS PER INTERNATIONAL NORMALISED RATIO. | U | 0 | |||||||||
| 125860641 | 12586064 | 3 | SS | INDOMETHACIN. | INDOMETHACIN | 1 | Oral | 50 MG X 6 CAPSULES | 12450 | MG | U | 0 | 50 | MG | Q8H | ||||
| 125860641 | 12586064 | 4 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | U | U | 0 | |||||||||
| 125860641 | 12586064 | 5 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | 125 ?G, DAILY | U | U | 0 | 125 | UG | ||||||
| 125860641 | 12586064 | 6 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | U | U | 0 | |||||||||
| 125860641 | 12586064 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 40 MG, DAILY | U | U | 0 | 40 | MG | ||||||
| 125860641 | 12586064 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 10 MG, DAILY | U | U | 0 | 10 | MG | ||||||
| 125860641 | 12586064 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 2.5 MG, DAILY | U | U | 0 | 2.5 | MG | ||||||
| 125860641 | 12586064 | 10 | C | SALMETEROL | SALMETEROL | 1 | Respiratory (inhalation) | U | U | 0 | |||||||||
| 125860641 | 12586064 | 11 | C | VIAZEM XL | DILTIAZEM HYDROCHLORIDE | 1 | Unknown | 6 MG, DAILY | U | U | 0 | 6 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125860641 | 12586064 | 1 | Product used for unknown indication |
| 125860641 | 12586064 | 2 | Atrial fibrillation |
| 125860641 | 12586064 | 3 | Product used for unknown indication |
| 125860641 | 12586064 | 4 | Product used for unknown indication |
| 125860641 | 12586064 | 5 | Product used for unknown indication |
| 125860641 | 12586064 | 6 | Product used for unknown indication |
| 125860641 | 12586064 | 7 | Product used for unknown indication |
| 125860641 | 12586064 | 8 | Product used for unknown indication |
| 125860641 | 12586064 | 9 | Product used for unknown indication |
| 125860641 | 12586064 | 10 | Product used for unknown indication |
| 125860641 | 12586064 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125860641 | 12586064 | HO |
| 125860641 | 12586064 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125860641 | 12586064 | Contraindicated product administered | |
| 125860641 | 12586064 | Haemarthrosis | |
| 125860641 | 12586064 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125860641 | 12586064 | 1 | 20160330 | 20160401 | 0 | |
| 125860641 | 12586064 | 3 | 20160324 | 20160326 | 0 |